Atlas Trials

A Study of Different Injectable Formulations of LY3375880 in Healthy Participants

Clinical trial NCT03913260 · COMPLETED

Trial details

NCT number
NCT03913260
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-05-01
Primary completion
2019-09-19
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.